LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report

BACKGROUND: Rearrangements of the anaplastic lymphoma kinase (ALK) gene comprise a small subset of non-small cell lung cancer (NSCLC). Patients with NSCLC harboring ALK fusion proteins are sensitive to ALK tyrosine kinase inhibitors (TKIs). Various fusion partners of ALK are being discovered with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanlong, Zheng, Hongbo, Li, Zizhe, Shi, Shuchen, Zhong, Lang, Gong, Longlong, Lan, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162556/
https://www.ncbi.nlm.nih.gov/pubmed/35664754
http://dx.doi.org/10.3389/fonc.2022.841493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162556/
https://www.ncbi.nlm.nih.gov/pubmed/35664754
http://dx.doi.org/10.3389/fonc.2022.841493

Ejemplares similares